INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
154 hedge funds and large institutions have $1.15B invested in Insys Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 53 increasing their positions, 52 reducing their positions, and 23 closing their positions.
Holders
154
Holders Change
+9
Holders Change %
+6.21%
% of All Funds
4.04%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
32
Increased
53
Reduced
52
Closed
23
Calls
$17M
Puts
$16.1M
Net Calls
+$976K
Net Calls Change
+$42.8M
Top Buyers
| 1 |
SCM
1
Scopia Capital Management
New York
|
$167M |
| 2 |
GAM
2
Gotham Asset Management
New York
|
$23.8M |
| 3 |
AA
3
Antipodean Advisors
New York
|
$16.3M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$65.2M |
| 5 |
VM
5
Valinor Management
New York
|
$16.8M |
